Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats

Liver Transplantation

Volumn 10, Issue 3, 2004, Pages 379-391

  Fujino, Masayuki ^a   Kitazawa, Yusuke ^a   Kawasaki, Mikiko ^a   Funeshima, Naoko ^a   Kimura, Hiromitsu ^a   Nakajima, Toshiharu ^a   Saito, Hirohisa ^a   Li, Xiao Kang ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TACROLIMUS;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG DOSE REGIMEN; EXPRESSED SEQUENCE TAG; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE PROBE; GENE TECHNOLOGY; GRAFT REJECTION; HLA MATCHING; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; ISOGRAFT; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; RECIPIENT; REGULATORY MECHANISM; SURVIVAL TIME; UPREGULATION;

ANIMALS; GENE EXPRESSION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOCYTES; MALE; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RNA, MESSENGER; TACROLIMUS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, ISOGENEIC;

EID: 1642265806     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20082     Document Type: Article

References (71)

1. Wood KJ. New concepts in tolerance. Clin Transplant 1996;10: 93-99.
2. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, et al.T"INfectious" transplantation tolerance. Science 1993;259:974-977.
3. Seddon B, Mason D. The third function of the thymus. Immunol Today 2000;21:95-99.
4. Shevach EM. Regulatory T cells in autoimmmunity*. Annu Rev Immunol 2000;18:423-449.
5. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, KupiecTWeglinski JW. Induction of "iNfectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996;157: 1944-1950.
6. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-1582.
7. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance. Hepatology 1993;17: 1127-1152.
8. Starzl TE, Zinkernagel RM. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998;339:1905-1913.
9. Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 2000;101:455-458.
10. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-822.
11. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
12. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184:387-396.
13. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
14. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
15. Piccirillo CA, Shevach EM. Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167:1137-1140.
16. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 2002;168:5558-5565.
17. Chiffoleau E, Beriou G, Dutartre P, Usal C, Soulillou JP, Cuturi MC. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol 2002;168:5058-5069.
18. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A 1997;94:695-700.
19. Sharma VK, Bologa RM, Li B, Xu GP, Lagman M, Hiscock W, et al. Molecular executors of cell death - differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 1996;62:1860-1866.
20. McLean AG, Hughes D, Welsh KI, Gray DW, Roake J, Fuggle SV, et al. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 1997;63:374-380.
21. Zheng XX, Schachter AD, Vasconcellos L, Strehlau J, Tian Y, Shapiro M, et al. Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. Transplantation 1998;65:1512-1515.
22. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechool 1996;14:1675-1680.
23. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470.
24. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257:967-971.
25. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995;270:484-487.
26. Pietu G, Alibert O, Guichard V, Lamy B, Bois F, Leroy E, et al. Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array. Genome Res 1996;6:492-503.
27. Vasmatzis G, Essand M, Brinkmann U, Lee B, Pastan I. Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis. Proc Natl Acad Sci U S A 1998;95:300-304.
28. Whitney LW, Becker KG, Tresser NJ, Caballero-Ramos CI, Munson PJ, Prabhu VV, et al. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann Neurol 1999;46:425-428.
29. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 1999;96:6745-6750.
30. Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, et al. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res 1999;59:5464-5470.
31. Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999;229:101-108.
32. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 1999;154:981-986.
33. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
34. Alizadeh A. Eisen M, Botstein D, Brown PO, Staudt LM. Probing lymphocyte biology by genomic-scale gene expression analysis. J Clin Immunol 1998;18:373-379.
35. Glynne R, Akkaraju S, Healy JI, Rayner J, Goodnow CC, Mack DH. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 2000;403:672-676.
36. Marrack P, Mitchell T, Hildeman D, Kedl R, Teague TK, Bender J, et al. Genomic-scale analysis of gene expression in resting and activated T cells. Curr Opin Immunol 2000;12: 206-209.
37. Wodicka L, Dong H, Mittmann M, Ho MH, Lockhart DJ. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 1997;15:1359-367.
38. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000;405:827-836.
39. Kamada N, Davies HS, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981;292:840-842.
40. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-229.
41. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994;171:131-137.
42. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997;100:3173-3183.
43. Li XK, Tamura A. Fujino M, Guo L, Kakefuda T, Funeshima N, et al. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720. Clin Exp Immunol 2001;123: 331-339.
44. Saiura A, Mataki C, Murakami T, Umetani M, Wada Y, Kohro T, et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 2001;72:320-329.
45. Brown PO, Borstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 1999;21:33-37.
46. Gerhold D, Rushmore T, Caskey CT. DNA chips: Promising toys have become powerful tools. Trends Biochem Sci 1999;24: 168-173.
47. Fujino M, Funeshima N, Kitazawa Y, Kimura H, Amemiya H, Suzuki S, et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003;305:70-77.
48. Waldmann H, Cobbold S. Regulating the immune response to transplants. a role for CD4+ regulatory cell? Immunity 2001; 14:399-406.
49. Cobbold S, Waldmann H. Infectious tolerance. Curr Opin Immunol 1998;10:518-524.
50. Hall BM, Pearce NW, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990;171:141-157.
51. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol 1998;16:619-644.
52. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: Kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994;24:2383-2392.
53. Onodera K, Volk HD, Ritter T, Kupiec-Weglinski JW. Thymus requirTment and antigen dependency in the "iNfectious" tolerance pathway in transplant recipients. J Immunol 1998;160: 5765-5772.
54. Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001;1:233-239.
55. Dresske B, Lin X, Huang DS, Zhou X, Fandrich F. Spontaneous tolerance: Experience with the rat liver transplant model. Hum Immunol 2002;63:853-861.
56. Shimizu Y, Goto S, Lord R, Vari F, Edwards-Smith C, Chiba S, et al. Restoration of tolerance to rat hepatic allografts by spleen-derived passenger leukocytes. Transpl Int 1996;9:593-595.
57. Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997;158:5676-5684.
58. Bishop GA, Sun J, Shed AG, McCaughan GW. High-dose/activation-associated tolerance: A mechanism for allograft tolerance. Transplantation 1997;64:1377-1382.
59. Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, et al. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Transpl Immunol 2003;12:41-48.
60. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat Genet 1999;21:10-14.
61. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, et al. Complementary DNA sequencing: Expressed sequence tags and human genome project. Science 1991;252:1651-1656.
62. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, et al. Functional discovery via a compendium of expression profiles. Cell 2000;102:109-126.
63. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, et al. CD4(+)CD25(+) immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
64. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002;3:33-41.
65. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 1997;89:1708-1715.
66. Oelmann E, Herbst H, Zuhlsdorf M, Albrecht O, Nolte A, Schmitmann C, et al. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 2002;99:258-267.
67. Lim MS, Guedez L, Stetler-Stevenson WG, Stetler-Stevenson M. Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes. Ann N Y Acad Sci 1999;878:522-523.
68. Baker AH, Wilkinson GW, Hembry RM, Murphy G, Newby AC. Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells. Matrix Biol 1996;15:383-395.
69. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002;168:1080-1086.
70. Rivas JM, Ullrich SE. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992;149:3865-3871.
71. Kita Y, Li XK, Ohba M, Funeshima N, Enosawa S, Tamura A, et al. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene. Transplantation 1999;68:758-766.